Skip to main content
. Author manuscript; available in PMC: 2020 Aug 5.
Published in final edited form as: Circ Cardiovasc Interv. 2020 Feb 5;13(2):e008494. doi: 10.1161/CIRCINTERVENTIONS.119.008494

Table 1.

Baseline Clinical and Demographic Characteristics of the Study Patients

Stent-Only (n=185) Balloon-Stent (n=390) P Value
Age 68.48±7.35 68.65±7.66 0.91
Men, n (%) 183 (99%) 390 (100%) 0.10
Diabetes mellitus, n (%) 111 (60%) 234 (60%) 1.00
Current smoking, n (%) 46 (25%) 83 (21%) 0.34
Hypertension, n (%) 179 (97%) 374 (96%) 0.62
Hyperlipidemia 183 (99%) 376 (96%) 0.09
Indication for PCI, n (%)
 Stable angina 71 (38%) 146 (37%) 0.95
 Unstable angina 57 (31%) 120 (31%)
 NSTEMI 41 (22%) 94 (24%)
 Other 16 (9%) 30 (8%)
Number of diseased coronary vessels, n (%)
 None 0 (0%) 1 (0%) 0.95
 1-vessel 3 (2%) 8 (2%)
 2-vessel 18 (10%) 36 (9%)
 3-vessel 161 (87%) 334 (86%)
 Other 3 (2%) 10 (3%)
Prior MI, n (%) 94 (51%) 210 (54%) 0.50
LVEF, % 49.92±14.82 49.31±12.70 0.39
Congestive heart failure, n (%) 67 (36%) 137 (35%) 0.80
Body mass index (kg/m2) 30.67±5.89 30.44±5.31 0.91
PreIndex PCI estimated GFR (mean) 77.13±24.87 76.96±23.86 0.84
History of atrial fibrillation, n (%) 35 (19%) 70 (18%) 0.78
Peripheral arterial disease, n (%) 33 (18%) 70 (18%) 0.97

GFR indicates glomerular filtration rate; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction; and PCI, percutaneous coronary intervention.